Lead sponsor
Ruijin Hospital
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
2
Ongoing
130
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 4
1
Trials by status
Not yet recruiting
1
Active, not recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's DiseaseMCI due to AD / mild AD dementiaPh 4Active, not recruiting80
Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe DementiaAge 60-80Ph 1/2Not yet recruiting50